Fig. 2From: Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case reportAfter two courses of capecitabine + oxaliplatin, the size of the metastatic lymph node was 47 mm × 43 mm (arrow)Back to article page